Investing Profile

Jim Tananbaum

VCInvestorCEOFounder
Founder and CEO at Foresite Capital Management
foresitecapital.com/people/ji...San Francisco, California
Photo of Jim Tananbaum, Foresite Capital Management

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
5854 CONNECTIONS
Harvard Business School Network
838 CONNECTIONS
Massachusetts Institute of Technology Network
632 CONNECTIONS
Massachusetts Institute of Technology Network
632 CONNECTIONS
Yale University Network
416 CONNECTIONS
cb
$100K - $5.0M
$1.5M
36

Sign in to see all 23 investments on record.

Sign in with Google →
Founder and CEO Foresite Capital ManagementPresent
Co-Founder and Managing Director PVP2 & PVP3 Prospect Venture PartnersPresent
Co-Founder and Chief Executive Officer Theravance (THRX)Present
Founder and CEO Foresite CapitalPresent
Co-Founder and Chief Executive Officer Theravance Biopharma US, LLCPresent
Partner SIERRA VenturesPresent
Co-Founder. Board Member. GelTex (acquired Genzyme $1.6 B)Present
Co-Founder. Board Member. HotmailPresent
Product Manager, Prilosec MerckPresent
Co-Founder. Board Member. Barron Park AssociationPresent
Partner Sierra Ventures1993 - 1997
Co-Founder and CEO GelTex (acquired by Genzyme for $1.6 B)1991 - 1992
Harvard Business School mba
Harvard Medical School Doctor of Medicine (MD)
Massachusetts Institute of Technology Master of Science (M.S.) HST - information theory
Yale University BS BSEE, Math, computer science
Yale University BS, BSEE Math, computer science
Yale University BS BSEE, Applied Math, Electrical Engineering/Computer Science
Yale University BS, BSEE Applied Math, Electrical Engineering/Computer Science
Harvard Medical School Doctoral Affiliation Health, Science, and Technology
Massachusetts Institute of Technology Doctoral Affiliation Health, Science, and Technology
Sign in with Google →
Sign in with Google →